Nitrofurazone
CAS 59-87-0
Nitrofurazone (CAS 59-87-0) is a Phase 4 pharmaceutical compound with 3 bioactivity targets and 1,538 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 35330.64788732395 nM | 60 | - |
| - | MIC | 17.0425 ug.mL-1 | 40 | - |
| - | AC50 | 28241.876315789475 nM | 35 | - |
| - | IC50 | 29718.985925925925 nM | 26 | - |
| - | EC50 | 13142 nM | 5 | - |
| - | AC50 | 97.68 % | 1 | - |
| Glucose-6-phosphate 1-dehydrogenase Enzyme |
- | - | - | Homo sapiens |
| Snake venom metalloproteinase Bap1 Enzyme |
IC50 | 4.06 | - | Bothrops asper |
| Sterile alpha and TIR motif-containing protein 1 Unclassified |
IC50 | 4.05 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Nitrofurazone used for in pharmaceutical contexts?
Nitrofurazone (CAS 59-87-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Nitrofurazone?
Nitrofurazone has 1,538 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Accidental overdose. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Nitrofurazone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for NITROFURAZONE with EU status "permitted".
What clinical phase is Nitrofurazone in?
Nitrofurazone is rendered with ChEMBL max phase 4 (approved).
What bioactivity targets are documented for Nitrofurazone?
Nitrofurazone has 9 bioactivity rows in this page query. Rendered target entries include Glucose-6-phosphate 1-dehydrogenase, Snake venom metalloproteinase Bap1, Sterile alpha and TIR motif-containing protein 1.